Latest News

Pregabalin effectively treats restless leg syndrome with less risk of worsening symptoms, study finds

A year-long study has found that pregabalin -- which is FDA-approved to treat nerve pain, seizures, and other conditions -- was effective in reducing symptoms of restless leg syndrome and that long-term pregabalin treatment was less likely than pramipexole -- one of several drugs that activate the dopamine neurotransmission system and are FDA approved for RLS treatment -- to cause worsening of symptoms.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Report recommends insurers use prescription monitoring data to reduce opioid abuse, deaths

  • Almost one-third of Canadian adults have experienced child abuse

  • Coming up with explanations helps children develop cause-and-effect thinking skills

  • Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches

  • Stroke treatment, outcomes improve with new initiative

  • Newly-approved brain stimulator offers hope for individuals with uncontrolled epilepsy

  • Cyber buddy is better than 'no buddy'

  • Innovation improves drowsy driver detection

  • Multiple sclerosis: Review of current treatments for physicians

  • Researchers compare hip width and sexual behavior

  •